Briefly, the achievements of the current research represent that CAF‐derived exosomes containing miR‐20a can promote chemoresistance and aggressive growth in recipient NSCLC tumour cells owing to the ability of this miRNA to modulate the PTEN/PI3K‐AKT signalling pathway (Figure 12). This evidence concerns the gene AKT1 and non-small cell lung carcinoma.